Comprehensive risk reduction in patients with atrial fibrillation: emerging diagnostic and therapeutic options--a report from the 3rd Atrial Fibrillation Competence NETwork/European Heart Rhythm Association consensus conference.
Standard
Comprehensive risk reduction in patients with atrial fibrillation: emerging diagnostic and therapeutic options--a report from the 3rd Atrial Fibrillation Competence NETwork/European Heart Rhythm Association consensus conference. / Kirchhof, Paulus; Lip, Gregory Y H; Gelder, Van; Isabelle, C; Bax, Jeroen; Hylek, Elaine; Kaab, Stefan; Wegscheider, Karl; Wegscheider, Karl; Boriani, Giuseppe; Brandes, Axel; Ezekowitz, Michael; Diener, Hans; Haegeli, Laurent; Heidbuchel, Hein; Lane, Deirdre; Willems, Stephan; Willems, Stephan; Dorian, Paul; Aunes-Jansson, Maria; Blomstrom-Lundqvist, Carina; Borentain, Maria; Breitenstein, Stefanie; Brueckmann, Martina; Cater, Nilo; Clemens, Andreas; Dobrev, Dobromir; Dubner, Sergio; Edvardsson, Nils G; Friberg, Leif; Goette, Andreas; Gulizia, Michele; Hatala, Robert; Horwood, Jenny; Szumowski, Lukas; Kappenberger, Lukas; Kautzner, Josef; Leute, Angelika; Lobban, Trudie; Meyer, Ralf; Millerhagen, Jay; Morgan, John; Muenzel, Felix; Nabauer, Michael; Baertels, Christoph; Oeff, Michael; Paar, Dieter; Polifka, Juergen; Ravens, Ursula; Rosin, Ludger; Stegink, W; Steinbeck, Gerhard; Vardas, Panos; Vincent, Alphons; Walter, Maureen; Breithardt, Günter; Camm, A John.
In: EUROPACE, Vol. 14, No. 1, 1, 2012, p. 8-27.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - Comprehensive risk reduction in patients with atrial fibrillation: emerging diagnostic and therapeutic options--a report from the 3rd Atrial Fibrillation Competence NETwork/European Heart Rhythm Association consensus conference.
AU - Kirchhof, Paulus
AU - Lip, Gregory Y H
AU - Gelder, Van
AU - Isabelle, C
AU - Bax, Jeroen
AU - Hylek, Elaine
AU - Kaab, Stefan
AU - Wegscheider, Karl
AU - Wegscheider, Karl
AU - Boriani, Giuseppe
AU - Brandes, Axel
AU - Ezekowitz, Michael
AU - Diener, Hans
AU - Haegeli, Laurent
AU - Heidbuchel, Hein
AU - Lane, Deirdre
AU - Willems, Stephan
AU - Willems, Stephan
AU - Dorian, Paul
AU - Aunes-Jansson, Maria
AU - Blomstrom-Lundqvist, Carina
AU - Borentain, Maria
AU - Breitenstein, Stefanie
AU - Brueckmann, Martina
AU - Cater, Nilo
AU - Clemens, Andreas
AU - Dobrev, Dobromir
AU - Dubner, Sergio
AU - Edvardsson, Nils G
AU - Friberg, Leif
AU - Goette, Andreas
AU - Gulizia, Michele
AU - Hatala, Robert
AU - Horwood, Jenny
AU - Szumowski, Lukas
AU - Kappenberger, Lukas
AU - Kautzner, Josef
AU - Leute, Angelika
AU - Lobban, Trudie
AU - Meyer, Ralf
AU - Millerhagen, Jay
AU - Morgan, John
AU - Muenzel, Felix
AU - Nabauer, Michael
AU - Baertels, Christoph
AU - Oeff, Michael
AU - Paar, Dieter
AU - Polifka, Juergen
AU - Ravens, Ursula
AU - Rosin, Ludger
AU - Stegink, W
AU - Steinbeck, Gerhard
AU - Vardas, Panos
AU - Vincent, Alphons
AU - Walter, Maureen
AU - Breithardt, Günter
AU - Camm, A John
PY - 2012
Y1 - 2012
N2 - While management of atrial fibrillation (AF) patients is improved by guideline-conform application of anticoagulant therapy, rate control, rhythm control, and therapy of accompanying heart disease, the morbidity and mortality associated with AF remain unacceptably high. This paper describes the proceedings of the 3rd Atrial Fibrillation NETwork (AFNET)/European Heart Rhythm Association (EHRA) consensus conference that convened over 60 scientists and representatives from industry to jointly discuss emerging therapeutic and diagnostic improvements to achieve better management of AF patients. The paper covers four chapters: (i) risk factors and risk markers for AF; (ii) pathophysiological classification of AF; (iii) relevance of monitored AF duration for AF-related outcomes; and (iv) perspectives and needs for implementing better antithrombotic therapy. Relevant published literature for each section is covered, and suggestions for the improvement of management in each area are put forward. Combined, the propositions formulate a perspective to implement comprehensive management in AF.
AB - While management of atrial fibrillation (AF) patients is improved by guideline-conform application of anticoagulant therapy, rate control, rhythm control, and therapy of accompanying heart disease, the morbidity and mortality associated with AF remain unacceptably high. This paper describes the proceedings of the 3rd Atrial Fibrillation NETwork (AFNET)/European Heart Rhythm Association (EHRA) consensus conference that convened over 60 scientists and representatives from industry to jointly discuss emerging therapeutic and diagnostic improvements to achieve better management of AF patients. The paper covers four chapters: (i) risk factors and risk markers for AF; (ii) pathophysiological classification of AF; (iii) relevance of monitored AF duration for AF-related outcomes; and (iv) perspectives and needs for implementing better antithrombotic therapy. Relevant published literature for each section is covered, and suggestions for the improvement of management in each area are put forward. Combined, the propositions formulate a perspective to implement comprehensive management in AF.
KW - Animals
KW - Humans
KW - Male
KW - Female
KW - Treatment Outcome
KW - Rats
KW - Biological Markers/analysis
KW - Risk Reduction Behavior
KW - Anti-Arrhythmia Agents/therapeutic use
KW - Atrial Fibrillation/diagnosis/drug therapy/physiopathology/therapy
KW - Fibrinolytic Agents/therapeutic use
KW - Animals
KW - Humans
KW - Male
KW - Female
KW - Treatment Outcome
KW - Rats
KW - Biological Markers/analysis
KW - Risk Reduction Behavior
KW - Anti-Arrhythmia Agents/therapeutic use
KW - Atrial Fibrillation/diagnosis/drug therapy/physiopathology/therapy
KW - Fibrinolytic Agents/therapeutic use
M3 - SCORING: Journal article
VL - 14
SP - 8
EP - 27
JO - EUROPACE
JF - EUROPACE
SN - 1099-5129
IS - 1
M1 - 1
ER -
